Join us for Breast Cancer Calendar Party!

Strike Out Breast Cancer Bowling Event on Valentines Day is BACK!

February 14,  2017
Strike Out Breast Cancer this Valentine’s Day at The Back Bowl with
The Vail Breast Cancer Awareness Group

What: Strike Out Breast Cancer Bowling Event
When: Tuesday, February 14th, 2017
Where:The Back Bowl in Eagle
Time: 6:30pm-9:00pm

Entry fee is $450 per team of 6, $150 per couple or $75 per person. Sponsorship’s are available for $600 per team.

The fee includes a lite dinner fare platter, 1 bottle of Prosecco per team, shoe rental, and one hour of bowling.  There will also be an additional hour round of bowling for those that make it to the championship game.  All payment and team registration must be received by February 10th at 6:00pm in order to participate.  There will be a prize for Best Team Costume and overall winner so start thinking of fun ideas!


We will hold a raffle and have a signature pink drink with proceeds benefiting the Vail Breast Cancer Awareness Group if you are unable to bowl but still want to support the cause.

For registration forms or raffle tickets please email Jessica Denton at The Vail Breast Cancer Awareness Group at


Raffle Prizes

Pave Baby Bear dressed in rose gold with pink sapphires to signify Breast Cancer awareness from the Golden Bear

Taste of Vail
Debut of Rose
Wednesday April 5, 2017
3-6 PM
Two Passes
Taste of Vail
Lamb Cook-Off Apres Ski Tasting
Thursday, April 6, 2017
3 – 6 PM
Two Passes
Two Festival Passes
Vail Film Festival
March 30 – April 2, 2017
Additional Raffle Prizes and gifts for the Team Winner!
*You do not need to be present to win
Raffle Ticket Prices: $10 each or 3 for $25
You can pre-purchase with visa or mastercard if you prefer
Thank you so much for your continued support and we hope to see you this Valentine’s Day!
The Vail Breast Cancer Awareness Group
Jessica Denton
The Vail Breast Cancer Awareness Group, PO Box 4043, Avon, CO 81620

CO Gives Day is Coming!


Support the Vail Breast Cancer Awareness Group on Colorado Gives Day!

Colorado’s largest one-day online giving event, presented by Community First Foundation and FirstBank, is coming up and we need your support.

On Tuesday, December 6, 2016, thousands of donors will come together to support Colorado nonprofits like ours. Last year, a record-breaking $26.2 million was raised for Colorado nonprofits, $772,541 of that was raised for nonprofits right here in Eagle County.

Check out our donation page on…/overview.

Give where you live, give where you play on Colorado Gives Day. Your support helps us continue to provide financial and emotional assistance to those diagnosed with breast cancer in the vail valley. Beginning today, donations can be scheduled ahead of time. Thank you as always for the support in this beautiful community.

Drinking after breast cancer


Alcohol use after breast cancer doesn’t increase your

chances of dying of the disease, new study shows, but it
does increase overall cancer risk
We’ve all heard that drinking booze – even in moderation – can bump your
risk for breast cancer. As a result, many women and men diagnosed with
the disease have either sworn off alcohol entirely or worry when they do
“I feel guilty often for drinking,” said Maile Feuerman, 40-year- old, stay-at-
home mom from Eureka, California, who was diagnosed with breast cancer
two years ago. “I don’t want to have to wonder if it comes back because I
did this. But I love my wine.”
A new study out of Fred Hutchinson Cancer Research Center offers a
glimmer of good news for those who’ve been diagnosed and treated for the
disease: moderate alcohol use after a breast cancer diagnosis won’t lead to
a lethal recurrence.
Alcohol use among breast cancer survivors has been linked to increased
risks of developing a breast cancer recurrence, i.e., finding more cancer in
a breast that’s already been diagnosed and, say, had a lumpectomy.
 Drinking also ups your risk of being diagnosed with a second breast
cancer in the opposite “healthy” breast.
However, when it comes to dying — usually the biggest concern for those
who’ve been diagnosed — there’s not much of an association. According to
epidemiologist and lead author Dr. Christopher Li, alcohol use after a
breast cancer diagnosis does not increase your risk of dying of the disease.
“Moderation is very important but our study supports previous studies in
suggesting that the occasional glass of wine does not seem to impact a
woman’s risk of dying of breast cancer,” he said.

Mammogram Guidelines Updated

mammogramAfter a thorough review of the benefits and limitations of mammograms, the nation’s top cancer-fighting organization is advising women that they can wait until they are 45 years old to start using the tests to screen for breast cancer.
New guidelines from the American Cancer Society also assure women that they can have fewer mammograms over the course of their lives.
The guidelines, published in Wednesday’s edition of the Journal of the American Medical Assn., are designed for women who are in good health and have no reason to suspect their risk of developing breast cancer is above average. The findings represent a departure from the group’s previous recommendation that all women with an average risk of breast cancer get annual mammograms starting at age 40.

THANK YOU to everyone for our first successful “Bradazzled” benefit!

JPeg for internet Thank you Ad
A very special thank you to everyone who made our first “Bradazzled” event such a success. We are deeply thankful to all the wonderful people who comprise this beautiful generous community of ours.

October is breast cancer awareness month, join us for “Bradazzled”!



October is breast cancer awareness month and it is right around the corner! Join us on Wednesday, October 14th 5:30pm-8:00pm at Galerie Zuger in Solaris for “Bradazzled”. We will have food, drink and a silent auction of bedazzled bras made by local artists.


Acupuncture Relieves AI-Related Aches

acupunctureOncology Times 9/10/15

VIENNA—Acupuncture treatments appear to relieve the common
musculoskeletal discomfort experienced by women taking aromatase inhibitors (AIs) to reduce the risk of recurrent breast cancer, researchers reported in a small, single-arm study.

Giovanni Giardina, MD, Senior Assistant in Oncology at Ospedale diCircolo e Fondazione Macchi reported that a study of Italian women with self-reported musculoskeletal pain, who were treated with acupuncture techniques, reported improvement in pain and quality of life on validated assessment instruments.

He and his coauthors enrolled 17 women in the study, and reported on outcomes for 16, all of whom were experiencing musculoskeletal pain as a result of long-term therapy with aromatase inhibitors. The women ranged in age from 49 to 78, with a median of 62.

“All patients had a significant improvement of musculoskeletal aromatase inhibitor-related pain,” Giardina reported, “and our study suggests that acupuncture may be a promising modality for relieving aromatase inhibitor-related musculoskeletal side effects.

Warning that Hormone Replacement Therapy Nullifies Benefits of Exercise in Breast Cancer Risk-Reduction




CHICAGO–Physical activity is known to reduce the risk of breast cancer–but all the benefit of that activity appears to be negated by taking hormone replacement therapy. That is the conclusion of a meta-analysis reported here at the American Society of Clinical Oncology Annual Meeting (Abstract 1561).


“If you are a runner you should not take hormone replacement therapy because the hormones appear to wipe out the benefit as far as prevention of breast cancer is concerned,” Cécile Pizot, MS, a biostatistician at the International Prevention Research Institute in France, said in an interview at her poster study.


“A lower risk of breast cancer among physically active women has been frequently reported, but the risk in women using hormone replacement therapy appears to be higher.”


Asked for her perspective, Stephanie Bernik, MD, Chief of Surgical Oncology at Lenox Hill Hospital in New York City, said: “Although it has been known that physical activity could reduce the risk of breast cancer and that hormone replacement could increase the risk of the disease, it is interesting that this meta-analysis showed that hormone replacement could actually negate the positive effects of exercise.


“Women who exercise often want to do what they can to feel young and stay healthy,” she continued. “Although we have known the negative effects of hormone therapy, doctors now have persuasive evidence that the negative effects of hormone replacement therapy override the positive effect of physical activity. Women should be encouraged to do what they can to live healthy lifestyles, with the understanding that it is difficult to justify the use of hormone replacement therapy as part of that equation.”

Memory problems may be linked to “Cancer” Brain, not “Chemo Brain.”

Memory problems and cognitive impairment in women with breast

cancer have traditionally been blamed on “chemo brain,” but a new

study shows that there may be problems even before patients start

on chemotherapy and suggests that cognitive problems may be

linked to cytokines released by the cancer.

The study was published online June 22 in the Journal of the National

Cancer Institute.

The study is the first to describe a relationship between cytokines and

patients with newly diagnosed breast cancer who have not yet

received any cancer treatment.

“Cognitive dysfunction in breast cancer patients has traditionally been

attributed to the effects of chemotherapy (‘chemo brain’). However,

our findings indicate that it is present even prior to any cancer

treatment,” commented first author Sunita Patel, PhD, a clinical

neuropsychologist at City of Hope Medical Center, in Duarte,


In general, “chemo brain” refers to the side effects of chemotherapy,

whereas “cancer brain” includes cognitive problems related to many

factors involved in cancer, including stress, she explained.

“It may be helpful for patients who are fearful about cognitive side

effects of chemotherapy to know that new research suggests non-

treatment-related factors play a role,” Dr Patel added.